drug
as of 2026-07-01tranylcypromine
Tranylcypromine
MeSH D014191
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Hannover Medical School
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
2
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
NCT00012558—Completed
KOLs & investigators
3
Helge Frieling, Prof., MDKOL score 5
Professor Gary Donohoe, Ph.D.KOL score 5
Michael C Davis, M.D., Ph.D.KOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
indication
KOL
Helge Frieling, Prof., MD
personKOL score 5
Professor Gary Donohoe, Ph.D.
personKOL score 5
Michael C Davis, M.D., Ph.D.
personKOL score 5